Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-27 @ 11:05 PM
Study NCT ID:
NCT01319903
Status:
COMPLETED
Last Update Posted:
2012-01-13
First Post:
2011-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
Sponsor:
InflaRx GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-18
First Submit QC Date:
None
Study First Post Date:
2011-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-01-12
Last Update Post Date:
2012-01-13
Last Update Post Date Type:
ESTIMATED